Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

Significant advances in our knowledge about interventions to prevent cardiovascular disease (CVD) have occurred since publication of the first female-specific recommendations for preventive cardiology in 1999.1 Despite research-based gains in the treatment of CVD, it remains the leading killer of women in the United States and in most developed areas of the world.2–3 In the United States alone, more than one half million women die of CVD each year, exceeding the number of deaths in men and the next 7 causes of death in women combined. This translates into approximately 1 death every minute.2 Coronary heart disease (CHD) accounts for the majority of CVD deaths in women, disproportionately afflicts racial and ethnic minorities, and is a prime target for prevention.1–2 Because CHD is often fatal, and because nearly two thirds of women who die suddenly have no previously recognized symptoms, it is essential to prevent CHD.2 Other forms of atherosclerotic/thrombotic CVD, such as cerebrovascular disease and peripheral arterial disease, are critically important in women. Strategies known to reduce the burden of CHD may have substantial benefits for the prevention of noncoronary atherosclerosis, although they have been studied less extensively in some of these settings. In the wake of the reports of the Women’s Health Initiative and the Heart and Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that combination hormone therapy was associated with adverse CVD effects, there is a heightened need to critically review and document strategies to prevent CVD in women.4–7 These studies underscore the importance of evidence-based practice for chronic disease prevention. Optimal translation and implementation of science to improve preventive care should include a rigorous process of evaluation and clear communication about the quantity and quality of evidence used to support clinical recommendations. Recently, there has been an increase in the …

[1]  W. Millar Folic acid supplementation. , 2004, Health reports.

[2]  J. Herlitz,et al.  Similar Risk Reduction of Death of Extended-Release Metoprolol Once Daily and Immediate-Release Metoprolol Twice Daily During 5 Years After Myocardial Infarction , 1999, Cardiovascular Drugs and Therapy.

[3]  V. Rastogi,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.

[4]  E. Ambrosioni,et al.  Clinical aspects of ACE inhibition in patients with acute myocardial infarction , 1996, Cardiovascular Drugs and Therapy.

[5]  J. Erikssen,et al.  Assessment of physical activity by questionnaire and personal interview with particular reference to fitness and coronary mortality , 2004, European Journal of Applied Physiology and Occupational Physiology.

[6]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[7]  S. Yusuf,et al.  Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[8]  C. Hennekens,et al.  An update on aspirin in the primary prevention of cardiovascular disease. , 2003, Archives of internal medicine.

[9]  K. Fox,et al.  Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.

[10]  Mary Cushman,et al.  Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[11]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[12]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[13]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[14]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[15]  A. Zwinderman,et al.  Secondary prevention with folic acid: effects on clinical outcomes. , 2003, Journal of the American College of Cardiology.

[16]  E. Antman,et al.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? , 2003, Circulation.

[17]  J. Manson,et al.  Dietary carotenoids and risk of coronary artery disease in women. , 2003, The American journal of clinical nutrition.

[18]  C. Kooperberg,et al.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. , 2003, JAMA.

[19]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[20]  M. Marmot,et al.  Leisure time physical activity and disease-specific mortality among men with chronic bronchitis: evidence from the Whitehall study. , 2003, American journal of public health.

[21]  P. Bath Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key. , 2003, Stroke.

[22]  L Murray,et al.  What level of physical activity protects against premature cardiovascular death? The Caerphilly study , 2003, Heart.

[23]  J. Manson,et al.  Fish and Long-Chain &ohgr;-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women , 2003, Circulation.

[24]  E. Rimm,et al.  A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. , 2003, The American journal of clinical nutrition.

[25]  D. Mozaffarian,et al.  Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed: The Cardiovascular Health Study , 2003, Circulation.

[26]  J. Shepherd,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .

[27]  R. Singh,et al.  Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high-risk patients (Indo-Mediterranean diet heart study): a randomized single-blind trial , 2003 .

[28]  M. Osler,et al.  No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. , 2003, Journal of clinical epidemiology.

[29]  P. Mehler,et al.  Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes , 2003, Circulation.

[30]  M. Schroll Physical activity in an ageing population , 2003, Scandinavian journal of medicine & science in sports.

[31]  D. Herrington,et al.  Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings. , 2003, Atherosclerosis.

[32]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[33]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[34]  O. Hess,et al.  Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. the swiss heart study: a randomized controlled trial☆ , 2003 .

[35]  Tiina H Rissanen,et al.  Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. , 2003, The Journal of nutrition.

[36]  A. Wierzbicki,et al.  The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. , 2004, Current medical research and opinion.

[37]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.

[38]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[39]  G. Tognoni,et al.  Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database. , 2002, American heart journal.

[40]  Kishore Shetty,et al.  Hormone replacement therapy , 2002, BMJ : British Medical Journal.

[41]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[42]  T. Meade,et al.  Bezafibrate in men with lower extremity arterial disease: randomised controlled trial , 2002, BMJ : British Medical Journal.

[43]  D. Pella,et al.  Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.

[44]  S. Yusuf,et al.  Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.

[45]  D. Graham,et al.  Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. , 2002, Archives of internal medicine.

[46]  M. Santini,et al.  Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. , 2002, The American journal of cardiology.

[47]  R. Collins,et al.  Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.

[48]  W. Aronow,et al.  Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. , 2002, The American journal of cardiology.

[49]  Nicholas Smith,et al.  Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction , 2002, Annals of Internal Medicine.

[50]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[51]  J. Manson,et al.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.

[52]  A. Reunanen,et al.  Flavonoid intake and risk of chronic diseases. , 2002, The American journal of clinical nutrition.

[53]  O. Hess,et al.  Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. , 2002, JAMA.

[54]  S. Yusuf,et al.  Effect of long-term therapy with ramipril in high-risk women. , 2002, Journal of the American College of Cardiology.

[55]  E. Benjamin,et al.  Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference. , 2002, Journal of the American College of Cardiology.

[56]  Deepak L. Bhatt,et al.  Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.

[57]  H. Sox,et al.  Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease , 2002, Annals of Internal Medicine.

[58]  R. Califf,et al.  Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.

[59]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[60]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[61]  Deborah Grady,et al.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). , 2002, JAMA.

[62]  Jiang He,et al.  Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. , 2002, The American journal of clinical nutrition.

[63]  V. Tikhonoff,et al.  Population-based studies improve outcome in hypertensive patients. , 2002, American journal of hypertension.

[64]  P. Veugelers,et al.  Dietary Iron as a Risk Factor for Myocardial Infarction , 2002, Canadian journal of public health = Revue canadienne de sante publique.

[65]  P. Serruys,et al.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[66]  R. Kronmal,et al.  Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[67]  A. Evans,et al.  Physical Activity and Coronary Event Incidence in Northern Ireland and France: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) , 2002, Circulation.

[68]  A. Hofman,et al.  Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. , 2002, The American journal of clinical nutrition.

[69]  L. Tavazzi,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002 .

[70]  M. Santini,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[71]  E. Topol,et al.  Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting. , 2002, The American journal of cardiology.

[72]  Steven Snapinn,et al.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.

[73]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[74]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.

[75]  R. Califf,et al.  Underuse of aspirin in a referral population with documented coronary artery disease. , 2002, The American journal of cardiology.

[76]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[77]  Deepak L. Bhatt,et al.  Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention , 2002, Circulation.

[78]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[79]  R. Schall,et al.  Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy. , 2002, Journal of the American College of Cardiology.

[80]  Deepak L. Bhatt,et al.  Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. , 2002, Journal of the American College of Cardiology.

[81]  A. Coats MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[82]  W. Aronow,et al.  Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. , 2002, The American journal of cardiology.

[83]  G. Berglund,et al.  Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy. , 2002, Scandinavian journal of public health.

[84]  Walter C Willett,et al.  Exercise type and intensity in relation to coronary heart disease in men. , 2002, JAMA.

[85]  S. Goodman,et al.  Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. , 2006, The Cochrane database of systematic reviews.

[86]  A. Folsom,et al.  Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[87]  E. Bolson,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.

[88]  F. Eberli,et al.  Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. , 2001, The New England journal of medicine.

[89]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[90]  P. Whelton,et al.  Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. , 2001, Archives of internal medicine.

[91]  A. Go,et al.  Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women , 2001, Circulation.

[92]  A. Folsom,et al.  Dietary catechins in relation to coronary heart disease death among postmenopausal women , 2001, Epidemiology.

[93]  J. Anderson,et al.  Obesity and disease management: effects of weight loss on comorbid conditions. , 2001, Obesity research.

[94]  A. Go,et al.  Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. , 2001, Journal of the American College of Cardiology.

[95]  M. Yu,et al.  Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. , 2001, American journal of epidemiology.

[96]  C. Viscoli,et al.  A clinical trial of estrogen-replacement therapy after ischemic stroke. , 2001, The New England journal of medicine.

[97]  B. Cosmi,et al.  Ticlopidine versus oral anticoagulation for coronary stenting. , 2001, The Cochrane database of systematic reviews.

[98]  V. Fuster,et al.  AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.

[99]  V. Fuster,et al.  AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Journal of the American College of Cardiology.

[100]  M. Lauer,et al.  Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. , 2001, JAMA.

[101]  M. Ezekowitz,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.

[102]  Jeroen J. Bax,et al.  Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. , 2001, European heart journal.

[103]  R B D'Agostino,et al.  Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop , 2001, Circulation.

[104]  K. Schenck-Gustafsson,et al.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 2001, Circulation.

[105]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[106]  F. Grodstein,et al.  Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study , 2001, Annals of Internal Medicine.

[107]  G. Schillaci,et al.  [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[108]  V. Fuster,et al.  Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. , 2001, Journal of the American College of Cardiology.

[109]  G. Albrektsen,et al.  Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. , 2001, The American journal of clinical nutrition.

[110]  Frank Hu,et al.  The Effect of Fruit and Vegetable Intake on Risk for Coronary Heart Disease , 2001, Annals of Internal Medicine.

[111]  L. Kalra,et al.  Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? , 2001, Archives of internal medicine.

[112]  T. Lakka,et al.  Low Dietary Folate Intake Is Associated With an Excess Incidence of Acute Coronary Events: The Kuopio Ischemic Heart Disease Risk Factor Study , 2001, Circulation.

[113]  R. Belardinelli,et al.  Exercise training intervention after coronary angioplasty: the ETICA trial. , 2001, Journal of the American College of Cardiology.

[114]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[115]  P. O’Connor,et al.  Physical inactivity and short-term all-cause mortality in adults with chronic disease. , 2001, Archives of internal medicine.

[116]  R. Lees,et al.  The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. , 2001, The American journal of cardiology.

[117]  M. Sclavo [Physical activity and risk for cardiovascular events in diabetic women]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[118]  P. Whelton,et al.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.

[119]  H. Diener,et al.  CARDIAC SAFETY IN THE EUROPEAN STROKE PREVENTION STUDY 2 (ESPS2) , 2001, International journal of clinical practice.

[120]  M. Biase,et al.  Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. , 2001, Journal of the American College of Cardiology.

[121]  I-Min Lee,et al.  Physical Activity and Coronary Heart Disease in Women: Is No Pain, No Gain Passé? , 2001 .

[122]  S. Ebrahim,et al.  Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation , 2001, BMJ : British Medical Journal.

[123]  J. Hsia,et al.  Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS) , 2001, Circulation.

[124]  L. Wallentin,et al.  Early statin treatment following acute myocardial infarction and 1-year survival. , 2001, JAMA.

[125]  S. Ebrahim,et al.  Exercise‐based Rehabilitation for Coronary Heart Disease , 2001, The Cochrane database of systematic reviews.

[126]  J. Manson,et al.  Physical Activity and Risk for Cardiovascular Events in Diabetic Women , 2001, Annals of Internal Medicine.

[127]  M. Thun,et al.  Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. , 2001, American journal of epidemiology.

[128]  G. de Gaetano Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. , 2001, Lancet.

[129]  L. Tavazzi,et al.  Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-prevenzione trial , 2001, Lipids.

[130]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[131]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[132]  F. Speizer,et al.  A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease , 2000, Annals of Internal Medicine.

[133]  L. Ramsay,et al.  Aspirin for primary prevention , 2000, BMJ : British Medical Journal.

[134]  J. Williamson,et al.  Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials , 2000, The Lancet.

[135]  C. Tudor-Locke,et al.  Revisiting the role of physical activity and exercise in the treatment of type 2 diabetes. , 2000, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[136]  S. Yusuf,et al.  The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.

[137]  J. Manson,et al.  Triggering of sudden death from cardiac causes by vigorous exertion. , 2000, The New England journal of medicine.

[138]  W. Willett,et al.  Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in women. , 2000, The American journal of clinical nutrition.

[139]  G. Oudit,et al.  Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature. , 2000, Canadian family physician Medecin de famille canadien.

[140]  K. Teo,et al.  Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) , 2000, Circulation.

[141]  M. Boaz,et al.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.

[142]  D Spiegelman,et al.  Prospective study of major dietary patterns and risk of coronary heart disease in men. , 2000, The American journal of clinical nutrition.

[143]  S. Cole,et al.  Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. , 2000, The American journal of clinical nutrition.

[144]  C. Meinert,et al.  Gender representation in trials. , 2000, Controlled clinical trials.

[145]  A. Nissinen,et al.  Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. , 2000, European heart journal.

[146]  N. Freemantle,et al.  Are beta‐blockers effective in patients who develop heart failure soon after myocardial infarction? A meta‐regression analysis of randomised trials , 2000, European journal of heart failure.

[147]  K. Meeter,et al.  Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. , 2000, Journal of the American College of Cardiology.

[148]  R S Paffenbarger,et al.  Physical Activity and Coronary Heart Disease in Men: The Harvard Alumni Health Study , 2000, Circulation.

[149]  J. Tu,et al.  Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarction , 2000, The Lancet.

[150]  Giuseppe Mancia,et al.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.

[151]  Thomas Hedner,et al.  Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.

[152]  K. Alberti,et al.  Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. , 2000, Archives of internal medicine.

[153]  C. Patrono,et al.  Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women. , 2000, Epidemiology.

[154]  L. García-Rodríguez,et al.  Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. , 2000, Circulation.

[155]  W C Willett,et al.  A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. , 2000, The American journal of clinical nutrition.

[156]  E. Feskens,et al.  Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. , 2000, American journal of epidemiology.

[157]  J. Kaprio,et al.  Physical activity and other risk factors in male twin-pairs discordant for coronary heart disease. , 2000, Atherosclerosis.

[158]  Barry R. Davis,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.

[159]  D. Cook,et al.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.

[160]  S. Wannamethee,et al.  Alcohol intake and mortality in middle aged men with diagnosed coronary heart disease , 2000, Heart.

[161]  R. Gillum,et al.  The relation between fish consumption, death from all causes, and incidence of coronary heart disease. the NHANES I Epidemiologic Follow-up Study. , 2000, Journal of clinical epidemiology.

[162]  C. Sudlow,et al.  Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. , 2000, The Cochrane database of systematic reviews.

[163]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[164]  C. Mulrow,et al.  Pharmacotherapy for hypertension in the elderly , 1998 .

[165]  M. Glanz,et al.  The Sharer , 2000, Annals of Internal Medicine.

[166]  G A Colditz,et al.  Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. , 2000, The New England journal of medicine.

[167]  W. Newton,et al.  Preventing stroke in patients with atrial fibrillation. , 2000, The Journal of family practice.

[168]  Illiam,et al.  THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .

[169]  ichard,et al.  FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .

[170]  F. Rank,et al.  PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE , 2000 .

[171]  J. Manson,et al.  Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. , 1999, The American journal of clinical nutrition.

[172]  S. Tsugane,et al.  Alcohol Consumption and All-Cause and Cancer Mortality among Middle-aged Japanese Men: Seven-year Follow-up of the JPHC Study Cohort I , 1999 .

[173]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[174]  R. D'Agostino,et al.  Comparison of past versus recent physical activity in the prevention of premature death and coronary artery disease. , 1999, American heart journal.

[175]  M. H. Phillips,et al.  Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme , 1999, Heart.

[176]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[177]  Å. Hjalmarson Prevention of sudden cardiac death with beta blockers. , 1999, Clinical cardiology.

[178]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[179]  J I Mann,et al.  The Oxford Vegetarian Study: an overview. , 1999, The American journal of clinical nutrition.

[180]  J. Manson,et al.  Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. , 1999, The American journal of clinical nutrition.

[181]  G A Colditz,et al.  A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. , 1999, The New England journal of medicine.

[182]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[183]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[184]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[185]  W Winkelstein,et al.  Work and leisure time physical activity and mortality in men and women from a general population sample. , 1999, Annals of epidemiology.

[186]  J. Manson,et al.  Dietary protein and risk of ischemic heart disease in women. , 1999, The American journal of clinical nutrition.

[187]  D. Waters,et al.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[188]  M. de Lorgeril,et al.  Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. , 1999, Circulation.

[189]  P. Whelton,et al.  Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[190]  M. Ezekowitz,et al.  Preventing stroke in patients with atrial fibrillation. , 1999, JAMA.

[191]  S. Oparil,et al.  Guide to Preventive Cardiology for Women , 1999 .

[192]  Eber,et al.  Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty , 1999, European journal of clinical investigation.

[193]  J. Vestbo,et al.  Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. , 1999, Journal of epidemiology and community health.

[194]  M. H. Phillips,et al.  Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme , 1999 .

[195]  I Vuori,et al.  Public health burden of coronary heart disease risk factors among middle-aged and elderly men. , 1999, Preventive medicine.

[196]  P. Whelton,et al.  Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.

[197]  A. Hofman,et al.  Dietary iron and risk of myocardial infarction in the Rotterdam Study. , 1999, American journal of epidemiology.

[198]  M. Pfeffer,et al.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.

[199]  J. Danesh,et al.  Coronary heart disease and iron status: meta-analyses of prospective studies. , 1999, Circulation.

[200]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[201]  Jean-Louis Martin,et al.  Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .

[202]  A. Salustri,et al.  Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. , 1999, Giornale italiano di cardiologia.

[203]  A. Hofman,et al.  Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.

[204]  M. Bell,et al.  Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. , 1999, Circulation.

[205]  CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[206]  J. Manson,et al.  Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. , 1999, The American journal of clinical nutrition.

[207]  L. Hansson The Hypertension Optimal Treatment study and the importance of lowering blood pressure. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[208]  S. MacMahon,et al.  An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. , 1999, Clinical and experimental hypertension.

[209]  Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group. , 1999, Hypertension.

[210]  S. Tsugane,et al.  Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. , 1999, American journal of epidemiology.

[211]  H. White,et al.  Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. , 1999, Journal of the American College of Cardiology.

[212]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[213]  S. Oparil,et al.  Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. , 1999, Circulation.

[214]  H. Helenius,et al.  Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) , 1998, The Lancet.

[215]  K. Gould,et al.  Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.

[216]  P. Whelton,et al.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.

[217]  S. Ebrahim,et al.  Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men. , 1998, Archives of internal medicine.

[218]  J. Manson,et al.  Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study , 1998, BMJ.

[219]  P Corey,et al.  The Impact of Excluding Non‐Leisure Energy Expenditure on the Relation between Physical Activity and Mortality in Women , 1998, Epidemiology.

[220]  W. Kannel,et al.  Cardiovascular risks of hypertension: lessons from observational studies. , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[221]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[222]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[223]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[224]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[225]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[226]  C. Cannon,et al.  Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE registry , 1998 .

[227]  B. Magnani,et al.  Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study , 1998 .

[228]  G. Nante,et al.  Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. , 1998, The American journal of cardiology.

[229]  M. Law,et al.  By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? , 1998, European Journal of Clinical Nutrition.

[230]  G. Boysen,et al.  Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. , 1998, Archives of internal medicine.

[231]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[232]  C. Glueck,et al.  Prospective assessment of coronary heart disease risk factors: the NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up. , 1998, Journal of the American College of Nutrition.

[233]  S Goya Wannamethee,et al.  Changes in physical activity, mortality, and incidence of coronary heart disease in older men , 1998, The Lancet.

[234]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[235]  R. Collins,et al.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither , 1998, BMJ.

[236]  S. Ripatti,et al.  Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. , 1998, Archives of internal medicine.

[237]  B. Materson,et al.  Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. , 1998, The American journal of cardiology.

[238]  B. Magnani,et al.  Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. , 1998, American heart journal.

[239]  D. Hegsted Dietary fat intake and the risk of coronary heart disease in women. , 1998, The New England journal of medicine.

[240]  C. Cannon,et al.  Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation. , 1998, Journal of the American College of Cardiology.

[241]  E. Barrett-Connor,et al.  Hormone replacement therapy, heart disease, and other considerations. , 1998, Annual review of public health.

[242]  N. Wintfeld,et al.  Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.

[243]  Svend Kreiner,et al.  Hormone replacement therapy and risk of non-fatal stroke , 1997, The Lancet.

[244]  T. Key,et al.  Dietary determinants of ischaemic heart disease in health conscious individuals , 1997, Heart.

[245]  L. Kuller,et al.  Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures. , 1997, Archives of internal medicine.

[246]  N J Wald,et al.  Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.

[247]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[248]  A. Kazanjian,et al.  Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. , 1997, The Canadian journal of cardiology.

[249]  N. Wu,et al.  Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group. , 1997, Chinese medical journal.

[250]  I. Vuori,et al.  Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women. , 1997, International journal of epidemiology.

[251]  A S Leon,et al.  Leisure Time Physical Activity and the 16-Year Risks of Mortality from Coronary Heart Disease and All-Causes in the Multiple Risk Factor Intervention Trial (MRFIT) , 1997, International journal of sports medicine.

[252]  R. Senior,et al.  Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. , 1997, Circulation.

[253]  B. Psaty,et al.  Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. , 1997, Archives of internal medicine.

[254]  J. Feldman,et al.  Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. , 1997, BMJ.

[255]  K. Malmberg Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[256]  W C Willett,et al.  Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. , 1997, American journal of epidemiology.

[257]  SergioCoccheri,et al.  Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation , 1997 .

[258]  F. Fattapposta,et al.  Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. , 1997, Stroke.

[259]  A. Dyer,et al.  Fish consumption and the 30-year risk of fatal myocardial infarction. , 1997, The New England journal of medicine.

[260]  D. Holmes,et al.  Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. , 1997, The New England journal of medicine.

[261]  B. Psaty,et al.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.

[262]  M. Evans,et al.  Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.

[263]  F. Nuttall,et al.  Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. , 1997, Archives of internal medicine.

[264]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[265]  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. , 1997, Lancet.

[266]  A. Zanchetti,et al.  Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. , 1997, Journal of hypertension.

[267]  R. Singh,et al.  Effect of diet and moderate exercise on central obesity and associated disturbances, myocardial infarction and mortality in patients with and without coronary artery disease. , 1996, Journal of the American College of Nutrition.

[268]  U. Goldbourt,et al.  Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study Group. , 1996, The American journal of cardiology.

[269]  M. Dennis A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[270]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[271]  P. Elwood,et al.  Dietary magnesium does not predict ischaemic heart disease in the Caerphilly cohort. , 1996, European journal of clinical nutrition.

[272]  T. Key,et al.  Dietary habits and mortality in 11 000 vegetarians and health conscious people: results of a 17 year follow up , 1996, BMJ.

[273]  Salim Yusuf,et al.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials , 1996, BMJ.

[274]  J Herlitz,et al.  Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. , 1996, European heart journal.

[275]  C. Berzuini,et al.  Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. , 1996, Circulation.

[276]  E. Rimm,et al.  Relation between Intake of Flavonoids and Risk for Coronary Heart Disease in Male Health Professionals , 1996, Annals of Internal Medicine.

[277]  K Steenland,et al.  Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. , 1996, Circulation.

[278]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[279]  T. Harris,et al.  Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. , 1996, The American journal of clinical nutrition.

[280]  E. Rimm,et al.  Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States , 1996, BMJ.

[281]  U. Goldbourt,et al.  Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, The American journal of cardiology.

[282]  B. Fridlund,et al.  Long-term effects of a comprehensive rehabilitation programme after myocardial infarction. , 1996, Scandinavian journal of caring sciences.

[283]  S. Ebrahim,et al.  Cigarette smoking in British men and selection for coronary artery bypass surgery. , 1996, Heart.

[284]  A. Folsom,et al.  Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.

[285]  P. Hamet,et al.  Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.

[286]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[287]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[288]  E. Rimm,et al.  Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. , 1996, JAMA.

[289]  L. Joseph,et al.  Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. , 1996, Journal of clinical epidemiology.

[290]  PD redaction,et al.  Implications of the Diabetes Control and Complications Trial , 1996, Diabetes Care.

[291]  S. Genuth Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.

[292]  B. Davis,et al.  Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. , 1996, Clinical and experimental hypertension.

[293]  Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. , 1996, Journal of the American College of Cardiology.

[294]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[295]  H. Hämäläinen,et al.  Reduction in sudden deaths and coronary mortality in myocardial infarction patients after rehabilitation. 15 year follow-up study. , 1995, European heart journal.

[296]  E. Lonn,et al.  Effects of ACE Inhibitors on Mortality When Started in the Early Phase of Myocardial Infarction: Evidence from the Larger Randomized Controlled Trials , 1995, Journal of cardiovascular risk.

[297]  A. Reunanen,et al.  Body iron stores, dietary iron intake and coronary heart disease mortality , 1995, Journal of internal medicine.

[298]  P. Macfarlane,et al.  Factors determining case fatality in myocardial infarction "who dies in a heart attack"? , 1995, British heart journal.

[299]  T. Sellers,et al.  Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. , 1995, American journal of public health.

[300]  A. Shaper,et al.  Weight change and risk of heart attack in middle-aged British men. , 1995, International journal of epidemiology.

[301]  J. Manson,et al.  Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. , 1995, American journal of epidemiology.

[302]  G A Colditz,et al.  A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. , 1995, Annals of epidemiology.

[303]  R. Hoover,et al.  EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT , 1995, Epidemiology.

[304]  E. Rimm,et al.  Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. , 1995, The New England journal of medicine.

[305]  S. Flocke,et al.  Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. , 1995, Archives of family medicine.

[306]  R. Collins,et al.  Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.

[307]  P. Macfarlane,et al.  Risk factors for sudden cardiac death in middle-aged British men. , 1995, Circulation.

[308]  M. Levois,et al.  Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature. , 1995, Regulatory toxicology and pharmacology : RTP.

[309]  C. Glueck,et al.  The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. , 1995, Journal of the American College of Nutrition.

[310]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[311]  H. White,et al.  Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. , 1995, Journal of the American College of Cardiology.

[312]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[313]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.

[314]  Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group. , 1995, European heart journal.

[315]  Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.

[316]  J. Manson,et al.  Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. , 1994, Archives of internal medicine.

[317]  L. Wilkins A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[318]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[319]  E. Casiglia,et al.  Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL). , 1994, Japanese heart journal.

[320]  I. Holme,et al.  Quality-adjusted meta-analysis of the hypertension/coronary dilemma. , 1994, American journal of hypertension.

[321]  P. Deedwania,et al.  Effects of Treatment on Outcome in Mildly Symptomatic Patients With Ischemia During Daily Life: The Atenolol Silent Ischemia Study (ASIST) , 1994, Circulation.

[322]  David C. Atkins,et al.  The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. , 1994, Archives of internal medicine.

[323]  K. McPherson,et al.  Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters , 1994, BMJ.

[324]  A. Reunanen,et al.  Antioxidant vitamin intake and coronary mortality in a longitudinal population study. , 1994, American journal of epidemiology.

[325]  P. Touboul,et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[326]  J M Venäläinen,et al.  Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. , 1994, The New England journal of medicine.

[327]  Stroke Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[328]  E. Rimm,et al.  Dietary iron intake and risk of coronary disease among men. , 1994, Circulation.

[329]  R. Krauss,et al.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). , 1994, Circulation.

[330]  A. G. Shaper,et al.  Physical activity, hypertension and risk of heart attack in men without evidence of ischaemic heart disease. , 1992, Journal of human hypertension.

[331]  A. Hall,et al.  ACE-inhibitor therapy after myocardial infarction--a new treatment strategy. , 1994, Zeitschrift fur Kardiologie.

[332]  GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. , 1994, Lancet.

[333]  A. Vinik,et al.  Implications of the Diabetes Control and Complications Trial , 1993, Diabetes Care.

[334]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[335]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[336]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[337]  J. Gapinski,et al.  Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. , 1993, Archives of internal medicine.

[338]  J. Feldman,et al.  Overweight, weight loss, and risk of coronary heart disease in older women. The NHANES I Epidemiologic Follow-up Study. , 1993, American journal of epidemiology.

[339]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[340]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[341]  J. Manson,et al.  Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.

[342]  P. Elwood,et al.  Diet and incident ischaemic heart disease: the Caerphilly Study , 1993, British Journal of Nutrition.

[343]  R S Paffenbarger,et al.  The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.

[344]  K Rodahl,et al.  Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.

[345]  J. Huttunen,et al.  Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population. , 1993, Annals of medicine.

[346]  S. Shapiro,et al.  A case-control study of myocardial infarction in relation to use of estrogen supplements. , 1993, American journal of epidemiology.

[347]  E. Eaker,et al.  The risk of acute myocardial infarction after estrogen and estrogen‐progestogen replacement , 1993, British journal of obstetrics and gynaecology.

[348]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[349]  N. Edvardsson,et al.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris , 1992, The Lancet.

[350]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[351]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[352]  J. Sabaté,et al.  A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. , 1992, Archives of internal medicine.

[353]  J. Cutler,et al.  Alcohol Use and Mortality from Coronary Heart Disease: The Role of High-Density Lipoprotein Cholesterol , 1992, Annals of Internal Medicine.

[354]  B. Fridlund,et al.  A supportive–educative caring rehabilitation programme; improvements of physical health after myocardial infarction , 1992 .

[355]  C. Isles,et al.  Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men , 1992, The Lancet.

[356]  A. G. Shaper,et al.  Physical activity and stroke in British middle aged men. , 1992, BMJ.

[357]  S. Roux,et al.  Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. , 1992, Journal of the American College of Cardiology.

[358]  H. Petrovitch,et al.  Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group. , 1992, Geriatrics.

[359]  C. Eaton Relation Of Physical Activity And Cardiovascular Fitness To Coronary Heart Disease, Part I: A Meta-Analysis Of The Independent Relation Of Physical Activity And Coronary Heart Disease , 1992, The Journal of the American Board of Family Medicine.

[360]  H. Petrovitch,et al.  ISOLATED SYSTOLIC HYPERTENSION : LOWERING THE RISK OF STROKE IN OLDER PATIENTS , 1992 .

[361]  S. Juul-Möller,et al.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. , 1992, Lancet.

[362]  E. Sonnenblick,et al.  Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. , 1992, European heart journal.

[363]  J. Cutler,et al.  Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. , 1992, Annals of internal medicine.

[364]  G A Colditz,et al.  Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. , 2004, Preventive medicine.

[365]  L. Wallentin,et al.  Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. , 1991, Journal of the American College of Cardiology.

[366]  B. Dahlöf,et al.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.

[367]  E. Antman,et al.  Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.

[368]  R Weatherall,et al.  Physical activity and ischaemic heart disease in middle-aged British men. , 1991, British heart journal.

[369]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[370]  J. Connett,et al.  Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT). , 1991, International journal of epidemiology.

[371]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[372]  J. Feldman,et al.  Is the Serum Cholesterol‐Coronary Heart Disease Relationship Modified by Activity Level in Older Persons? , 1991, Journal of the American Geriatrics Society.

[373]  J. Manson,et al.  A prospective study of aspirin use and primary prevention of cardiovascular disease in women. , 1991, JAMA.

[374]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[375]  J. Madans,et al.  Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. , 1991, American journal of obstetrics and gynecology.

[376]  G. Colditz,et al.  Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[377]  C. Naylor,et al.  Aspirin and fibrinolysis in acute myocardial infarction: meta-analytic evidence for synergy. , 1991, Journal of clinical epidemiology.

[378]  V. Fuster,et al.  Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). , 1990, The American journal of cardiology.

[379]  J. Manson,et al.  Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. , 1990, The American journal of medicine.

[380]  D. Mirvis,et al.  Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. , 1990, Archives of internal medicine.

[381]  L. Wilkins Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. , 1990, Circulation.

[382]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[383]  G A Colditz,et al.  A meta-analysis of physical activity in the prevention of coronary heart disease. , 1990, American journal of epidemiology.

[384]  L H Kuller,et al.  The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). , 1990, American journal of public health.

[385]  J. Boissel,et al.  Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol. , 1990, The American journal of cardiology.

[386]  C. Cimminiello,et al.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. , 1990, Circulation.

[387]  D. Beevers,et al.  A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers. , 1990, Journal of human hypertension.

[388]  J. Morris,et al.  Exercise in leisure time: coronary attack and death rates. , 1990, British heart journal.

[389]  GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. , 1990, Lancet.

[390]  W. Miall β‐Blockers vs. Thiazides in the Treatment of Hypertension: A Review of the Experience of the Large National Trials , 1990, Journal of cardiovascular pharmacology.

[391]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[392]  M. Bobbio Does post myocardial infarction rehabilitation prolong survival? A meta-analytic survey. , 1989, Giornale italiano di cardiologia.

[393]  P. Leren Prevention of coronary heart disease: some results from the Oslo secondary and primary intervention studies. , 1989, Journal of the American College of Nutrition.

[394]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[395]  W. L. Ooi,et al.  Treatment-induced blood pressure reduction and the risk of myocardial infarction. , 1989, JAMA.

[396]  V. Hawthorne,et al.  Passive smoking and cardiorespiratory health in a general population in the west of Scotland. , 1989, BMJ.

[397]  J. Buring,et al.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction. , 1989, Circulation.

[398]  T. Meade,et al.  The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. , 1989, Journal of epidemiology and community health.

[399]  J. Stamler,et al.  DIETARY CHOLESTEROL AND ISCHAEMIC HEART DISEASE , 1989, The Lancet.

[400]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[401]  L. Gatewood,et al.  Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey , 1989, Arteriosclerosis.

[402]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[403]  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.

[404]  R. Kronmal,et al.  Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. , 1988, The New England journal of medicine.

[405]  E. Barrett-Connor,et al.  Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. , 1988, American journal of epidemiology.

[406]  B. Butland,et al.  Heart disease in British vegetarians. , 1988, The American journal of clinical nutrition.

[407]  G. Guyatt,et al.  Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. , 1988 .

[408]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[409]  C. Bulpitt,et al.  The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). , 1988, Journal of human hypertension.

[410]  D. Reed,et al.  Physical activity and coronary heart disease in middle-aged and elderly men: the Honolulu Heart Program. , 1988, American journal of public health.

[411]  E. Chee,et al.  Heart disease mortality in nonsmokers living with smokers. , 1988, American journal of epidemiology.

[412]  E. Weber Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[413]  J. Tuomilehto,et al.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.

[414]  R. Rauramaa,et al.  Leisure time and occupational physical activity: risk of death from ischemic heart disease. , 1988, American journal of epidemiology.

[415]  The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group. , 1988, European heart journal.

[416]  C. Dollery,et al.  The Medical Research Council Hypertension Trial: the smoking patient. , 1988, American Heart Journal.

[417]  I. Wiklund,et al.  Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction. , 1988, Cardiology.

[418]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[419]  A S Leon,et al.  Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. , 1987, JAMA.

[420]  L. Kuller,et al.  Effects of passive smoking in the Multiple Risk Factor Intervention Trial. , 1987, American journal of epidemiology.

[421]  J. Tuomilehto,et al.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.

[422]  S. Sidney,et al.  Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. , 1987, Obstetrics and gynecology.

[423]  P. Sleight Beta blockade early in acute myocardial infarction. , 1987, The American journal of cardiology.

[424]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[425]  E. O'Brien,et al.  Treatment of Elderly Hypertensives: Results and Implications of Recent Trials , 1987, Journal of Cardiovascular Pharmacology.

[426]  J. Willerson,et al.  The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group. , 1987, European heart journal.

[427]  I. Bosaeus,et al.  Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, The American journal of clinical nutrition.

[428]  C. Bengtsson,et al.  Socioeconomic factors and physical activity in relation to cardiovascular disease and death. A 12 year follow up of participants in a population study of women in Gothenburg, Sweden. , 1986, British heart journal.

[429]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[430]  G. Wagner Summary of Short‐ and Long‐Term Studies with Bisoprolol in Coronary Heart Disease (CHD) , 1985, Journal of cardiovascular pharmacology.

[431]  Lewis Hd Unstable angina: status of aspirin and other forms of therapy. , 1985 .

[432]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[433]  P. Wilson,et al.  Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. , 1985, The New England journal of medicine.

[434]  S. Marra,et al.  Long-term follow-up after a controlled randomized post-myocardial infarction rehabilitation programme: effects on morbidity and mortality. , 1985, European heart journal.

[435]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[436]  R. Lew,et al.  Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. , 1985, The New England journal of medicine.

[437]  G. Cran,et al.  Very early intervention with metoprolol in suspected acute myocardial infarction. , 1985, European heart journal.

[438]  H. Lewis Unstable angina: status of aspirin and other forms of therapy. , 1985, Circulation.

[439]  C. Bengtsson,et al.  Morbidity and mortality in relation to blood pressure and antihypertensive treatment. A 12-year follow-up study of a population sample of Swedish women. , 2009, Acta medica Scandinavica.

[440]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[441]  D. Durrer,et al.  Effects of cardiac rehabilitation after myocardial infarction: changes in coronary risk factors and long-term prognosis. , 1983, American heart journal.

[442]  S. Johansson,et al.  Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. , 1983, British heart journal.

[443]  I. Lukšić,et al.  Cardiac Rehabilitation after Acute Myocardial Infarction , 1983 .

[444]  R. Shephard,et al.  Relation of exercise to the recurrence rate of myocardial infarction in men. Ontario Exercise-Heart Collaborative Study. , 1983, The American journal of cardiology.

[445]  A multicenter study on timolol in secondary prevention after myocardial infarction. , 1983, Acta medica Scandinavica. Supplementum.

[446]  I. Lukšić,et al.  Cardiac rehabilitation after acute myocardial infarction. 9-year controlled follow-up study. , 1983, Cardiology.

[447]  M. Neophytou,et al.  Exercise after Myocardial Infarction: A Controlled Trial , 1982, Journal of the Royal College of Physicians of London.

[448]  J. Lewis,et al.  Confidence in results of beta-blocker postinfarction trials. , 1982, British medical journal.

[449]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[450]  J. Salonen,et al.  Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. , 1982, American journal of epidemiology.

[451]  A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. , 1982, The New England journal of medicine.

[452]  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.

[453]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[454]  C. A. Gilbert,et al.  Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction: The National Exercise and Heart Disease Project∗☆ , 1981 .

[455]  K. Breddin,et al.  The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. , 1980, Circulation.

[456]  G. Rosenhamer,et al.  Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. , 1980, Atherosclerosis.

[457]  Lippincott Williams Wilkins,et al.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.

[458]  F. Gyntelberg,et al.  Physical fitness and risk of myocardial infarction in Copenhagen males aged 40-59: a five- and seven-year follow-up study. , 1980, Scandinavian journal of work, environment & health.

[459]  R. Peto,et al.  EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial , 1980, The Lancet.

[460]  The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. , 1980, Circulation.

[461]  P. Elwood,et al.  ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.

[462]  H. Hämäläinen,et al.  REDUCTION IN SUDDEN DEATHS BY A MULTIFACTORIAL INTERVENTION PROGRAMME AFTER ACUTE MYOCARDIAL INFARCTION , 1979, The Lancet.

[463]  E. Beckman,et al.  Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. , 1979, Obstetrics and gynecology.

[464]  K Uberla,et al.  Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.

[465]  P. Sorlie,et al.  Relation of lipids, weight and physical activity to incidence of coronary heart disease: the Puerto Rico heart study. , 1978, The American journal of cardiology.

[466]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[467]  J. Naughton The National Exercise and Heart Disease Project , 1978 .

[468]  The coronary drug project aspirin study. Implications for clinical care. Coronary Drug Project Research Group. , 1978, Primary care.

[469]  W. Martin,et al.  Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. , 1978, Journal of chronic diseases.

[470]  C. Mcgilchrist,et al.  Low fat, low cholesterol diet in secondary prevention of coronary heart disease. , 1978, Advances in experimental medicine and biology.

[471]  J. Stamler The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin. , 1977, Advances in experimental medicine and biology.

[472]  H. Jick,et al.  Myocardial infarction and estrogen therapy in post-menopausal women. , 1976, The New England journal of medicine.

[473]  J. Hakkila Morbidity and mortality after myocardial infarction. , 1976, Bibliotheca cardiologica.

[474]  A. Multicentre Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. , 1975, British medical journal.

[475]  E. C. Hammond,et al.  Aspirin and coronary heart disease: findings of a prospective study. , 1975, British medical journal.

[476]  C. Seltzer Smoking and coronary heart disease in the elderly , 1975, The American journal of the medical sciences.

[477]  J. Stamler Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[478]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[479]  P C Elwood,et al.  A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.

[480]  The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. , 1973, JAMA.